Lastly, pathway-based analyses show significant enrichment of lipid metabolism, autoimmunity, lipase inhibitors, PD-1 signalling and statin mechanisms, among others, for AD and GIT traits. This evidence concerns the gene PDCD1 and Alzheimer disease.